Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 7 of 7 entries
View as:

Combination Tissue Plasminogen Activator (Tpa) and Dornase Alfa (Dnase) Administration Through Intrapleural Catheters for the Treatment of Loculated or Non-Draining Malignant Pleural Effusions

Phase: N/A Priority: Normal
NCT ID: NCT02135588 Org: User:
Start: 10/31/13 End: 12/31/21 Due: 12/31/22

Does Serum Procalcitonin Levels Predict Sepsis in Patients Undergoing Cytoreductive Surgery

Phase: N/A Priority: Normal
NCT ID: NCT02189434 Org: User:
Start: 06/30/14 End: 04/30/16 Due: 04/30/17

Domperidone Expanded Access Program for Oncology Patients With Gastroparesis Who Have Failed Standard Therapy

Phase: N/A Priority: Normal
NCT ID: NCT02494687 Org: User:
Start: - End: - Due: -

Feasibility Study of Intraperitoneal Bevacizumab for Palliation of Intractable Malignant Ascites

Phase: N/A Priority: Normal
NCT ID: NCT02496286 Org: User:
Start: 06/30/15 End: 08/31/15 Due: 08/31/16

Pilot Study Investigating the Use of the ReBuilder to Treat Chemotherapy Induced Peripheral Neuropathy in Patients With Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02606110 Org: User:
Start: 06/30/14 End: - Due: -

L-glutamine Supplementation to Alleviate Symptoms of Taxane-Induced Neuropathy in Patients With Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02215083 Org: User:
Start: 08/31/14 End: 04/30/15 Due: 04/30/16

Safety & Efficacy Study of Gemcitabine...With High Dose IV Vit. C (HDIVC)

Phase: N/A Priority: Normal
NCT ID: NCT01654861 Org: User:
Start: 06/30/12 End: 06/30/14 Due: 06/30/15